Results 121 to 130 of about 76,283 (157)

Thromboembolism and Janus Kinase Inhibitors

Drug Safety, 2020
Fowzia Ibrahim, David L. Scott
openaire   +3 more sources

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Journal of Inflammation Research, 2023
Jin-Ying Lin
exaly  

INHIBITORS OF JANUS KINASES

2009
SIU TONY, YOUNG JONATHAN, ALTMAN MICHAEL, NORTHRUP ALAN, KATCHER MATTHEW, KUMARASINGHE ELLALAHEWAGE SATHYAJITH, KOZINA EKATERINA, PETERSON SCOTT, CHILDERS MATTHEW   +8 more
  +13 more sources

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study

Journal of the American Academy of Dermatology, 2023

exaly  

Janus kinases inhibitors

Cahiers Santé Médecine Thérapeutique, 2022
El Mehdi Boudhar, M El Mandour, Abdelhafid Elguich, Hajar Sahimi, Hasna Hassikou   +4 more
openaire   +1 more source

Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

Journal of the American Academy of Dermatology, 2022
John Frew
exaly  

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Janus Kinase

2006
openaire   +2 more sources

Janus kinases in immune cell signaling

Immunological Reviews, 2009
Kamran Ghoreschi, John O'Shea, Arian Laurence   +2 more
exaly  

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski, John C Vanrens, Michael P Clark   +2 more
exaly